Suite 600 – 1285 West Broadway
Vancouver BC V6H 3X8 Canada
Phone: (604) 551-6782
Member Sector: Biopharmaceuticals
At ImStar Therapeutics, we are developing a breakthrough new approach to treat patients with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s Disease. By exploiting a major new biological target behind the underlying disease, we expect to make great strides in treating this devastating neurological condition and other related neurodegenerative disorders such as Dementia, Alzheimer’s Disease and Parkinson’s Disease.